| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$9 ) |
| | 2025 | 2022 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R21AG070161 | Development and Proof-of-Concept Trial of a Meaning and Theory-Based Physical Activity Intervention | 000 | 2 | NIH | 10/15/2024 | -$9 |
|
| Issue Date FY: 2024 ( Subtotal = $10,599,498 ) |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD107753 | Maternal COVID-19 Vaccination and Lactation Outcomes | 001 | 3 | NIH | 5/21/2024 | $548,002 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | UG3DE030063 | Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings | 000 | 2 | NIH | 2/16/2024 | $326,990 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | UG3DE030063 | Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings | 002 | 2 | NIH | 7/10/2024 | $7,266 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | UG3DE030063 | Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings | 001 | 2 | NIH | 7/1/2024 | $29,066 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01CA283332 | Randomized Trial to Improve Care of Patients with Hereditary Cancer Syndromes | 000 | 1 | NIH | 3/8/2024 | $657,621 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R21AR082572 | ACL Reconstruction Rehabilitation with Exercise and Psychological Support | 000 | 1 | NIH | 9/20/2024 | $556,160 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | K22DE032046 | Exploring Mechanisms of Hepatitis C Virus-Associated Xerostomia | 000 | 2 | NIH | 6/20/2024 | $248,264 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD115580 | Neonatal, Lactation, and Child Health Outcomes Following RSV Vaccination During Pregnancy | 000 | 1 | NIH | 8/9/2024 | $732,591 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01CA263542 | The Interplay of ENDS and Tobacco Control Policy: Impact on the Population Harms of Tobacco | 000 | 3 | NIH | 9/13/2024 | $581,299 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01DK128281 | Reducing Clinical Inertia in Obesity Management of Diabetes in Primary Care: Cluster-Randomized Trial | 000 | 4 | NIH | 5/20/2024 | $615,063 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD100579 | Treatment Initiation for New Episodes of Depression in Pregnant Women | 001 | 4 | NIH | 5/3/2024 | $51,649 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD100579 | Treatment Initiation for New Episodes of Depression in Pregnant Women | 000 | 4 | NIH | 3/22/2024 | $516,497 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R18HS027402 | Improving Recognition and Management of Hypertension in Youth: Comparing Approaches for Extending Effective CDS for use in a Large Rural Health System | 000 | 5 | AHRQ | 6/21/2024 | $397,480 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R33AG069770 | A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment | 000 | 5 | NIH | 8/28/2024 | $1,455,139 |
| | 2024 | 2024 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | UG1CA189863 | Metro-Minnesota Community Oncology Research Consortium (MMCORC) | 000 | 12 | NIH | 7/23/2024 | $3,879,257 |
| | 2024 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD107753 | Maternal COVID-19 Vaccination and Lactation Outcomes | 000 | 2 | NIH | 2/16/2024 | $0 |
| | 2024 | 2022 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HL136937 | A Team-Based and Technology Driven Adherence Intervention to Improve Chronic Disease Outcomes | 000 | 5 | NIH | 3/1/2024 | $0 |
| | 2024 | 2021 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R18HS025618 | Optimizing the Value of PROMs in Improving Care Delivery through Health Information Technology | 000 | 5 | AHRQ | 11/28/2023 | -$713 |
| | 2024 | 2021 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R21AG074368 | Factors Associated with Healthcare Utilization Among Community-Dwelling Adults with Clinical Features of Dementia with Lewy Bodies | 000 | 1 | NIH | 10/17/2023 | $0 |
| | 2024 | 2020 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R18DK118463 | A Technology-Driven Intervention to Improve Identification and Management of Chronic Kidney Disease in Primary Care | 000 | 3 | NIH | 2/13/2024 | -$1,834 |
| | 2024 | 2020 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | U01DE027441 | De-Implementing Opioid Use and Implementing Optimal Pain Management Following Dental Extractions | 000 | 4 | NIH | 7/19/2024 | -$299 |
|
| Issue Date FY: 2023 ( Subtotal = $8,786,868 ) (Continued on the next page) |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01DK128281 | Reducing Clinical Inertia in Obesity Management of Diabetes in Primary Care: Cluster-Randomized Trial | 002 | 3 | NIH | 5/8/2023 | $116,920 |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01CA263542 | The Interplay of ENDS and Tobacco Control Policy: Impact on the Population Harms of Tobacco | 000 | 2 | NIH | 7/14/2023 | $580,352 |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | UG3DE030063 | Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings | 001 | 1 | NIH | 7/24/2023 | $53,708 |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | UG3DE030063 | Investigating Behavioral Mechanisms and Efficacy of a Provider-Directed Intervention for HPV Vaccine Promotion in Real-World Dental Settings | 000 | 1 | NIH | 1/26/2023 | $315,746 |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R33AG069770 | A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment | 003 | 4 | NIH | 8/16/2023 | $1,148,058 |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R33AG069770 | A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment | 004 | 4 | NIH | 8/25/2023 | $236,997 |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01DK128281 | Reducing Clinical Inertia in Obesity Management of Diabetes in Primary Care: Cluster-Randomized Trial | 001 | 3 | NIH | 5/5/2023 | $656,252 |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD100579 | Treatment Initiation for New Episodes of Depression in Pregnant Women | 000 | 3 | NIH | 3/29/2023 | $608,546 |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R18HS027402 | Improving Recognition and Management of Hypertension in Youth: Comparing Approaches for Extending Effective CDS for use in a Large Rural Health System | 000 | 4 | AHRQ | 6/28/2023 | $398,293 |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD107753 | Maternal COVID-19 Vaccination and Lactation Outcomes | 001 | 2 | NIH | 9/8/2023 | $250,296 |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HD107753 | Maternal COVID-19 Vaccination and Lactation Outcomes | 000 | 2 | NIH | 4/7/2023 | $602,839 |
| | 2023 | 2023 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | UG1CA189863 | Metro-Minnesota Community Oncology Research Consortium (MMCORC) | 002 | 11 | NIH | 7/19/2023 | $3,913,879 |
| | 2023 | 2022 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01DK128281 | Reducing Clinical Inertia in Obesity Management of Diabetes in Primary Care: Cluster-Randomized Trial | 000 | 2 | NIH | 2/3/2023 | $0 |
| | 2023 | 2022 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R33AG069770 | A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment | 002 | 3 | NIH | 2/8/2023 | $0 |
| | 2023 | 2022 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R33AG069770 | A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment | 000 | 3 | NIH | 11/9/2022 | $4,751 |
| | 2023 | 2022 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R33AG069770 | A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment | 001 | 3 | NIH | 12/5/2022 | $0 |
| | 2023 | 2022 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | UG1CA189863 | Metro-Minnesota Community Oncology Research Consortium (MMCORC) | 000 | 10 | NIH | 2/7/2023 | $0 |
| | 2023 | 2021 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R61AG069770 | A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment | 000 | 2 | NIH | 11/9/2022 | -$4,751 |
| | 2023 | 2021 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01AG052533 | Hotspotting Cardiometabolic Disparities for Simulated Advances in Population Care | 000 | 4 | NIH | 7/6/2023 | $0 |
| | 2023 | 2020 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | U01DE027441 | De-Implementing Opioid Use and Implementing Optimal Pain Management Following Dental Extractions | 000 | 4 | NIH | 1/23/2023 | $0 |
| | 2023 | 2020 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01CA193396 | Implementing Cancer Prevention Using Patient - Provider Clinical Decision Support | 001 | 5 | NIH | 5/15/2023 | -$3,291 |
| | 2023 | 2020 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01CA193396 | Implementing Cancer Prevention Using Patient - Provider Clinical Decision Support | 000 | 5 | NIH | 12/7/2022 | $0 |
| | 2023 | 2019 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | U01DE026135 | A Clinic-Randomized Trial of a Clinical Decision Support System to Improve Dental Provider Delivery of Brief Tobacco Interventions and Quitline Referrals | 000 | 4 | NIH | 11/8/2022 | $0 |
| | 2023 | 2019 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HL128614 | Reducing CV Risk in Prediabetes Patients Using EHR-Based Decision Support | 000 | 5 | NIH | 12/7/2022 | $2,490 |
| | 2023 | 2019 | HEALTHPARTNERS INSTITUTE | 8170 33RD AVE S | MINNEAPOLIS | MN | 55425-4516 | HENNEPIN | USA | R01HL128614 | Reducing CV Risk in Prediabetes Patients Using EHR-Based Decision Support | 001 | 5 | NIH | 2/2/2023 | -$4,627 |
|
